• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2004-2016 年伊朗北部戈勒斯坦省骨和软组织癌的发病率及时间变化。

Incidence and Temporal Variations of Bone and Soft Tissue Cancers in the Golestan Province, Northern Iran, 2004-2016.

机构信息

Golestan Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

Arch Iran Med. 2023 Feb 1;26(2):62-68. doi: 10.34172/aim.2023.11.

DOI:10.34172/aim.2023.11
PMID:37543925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10685894/
Abstract

BACKGROUND

This study was conducted to evaluate the epidemiological features of bone and soft cancers in the Golestan province, Northern Iran from 2004 to 2016.

METHODS

This is a descriptive cross-sectional study. All patients with primary bone and soft tissue cancers between 2004 and 2016 were included. Data were obtained from Golestan population-based cancer registry (GPCR). We calculated age-standardized incidence rates (ASRs) and reported the rates per 100000 person-year. Estimated annual percent change (EAPC) was also calculated to assess temporal trends in incidence rates of these cancers.

RESULTS

The ASRs of bone cancers and soft tissue cancers were 1.33 and 1.43 per 100000 person-year, respectively. This study also showed that the ASR of bone cancer was higher in men (1.51) than women (1.15). The ASR of soft tissue cancers in the urban population (1.58) was higher than rural (1.27), and was lower in women (1.37) than men (1.49). Two peaks were seen in the incidence of bone cancer. The first peak was in the age group of 10 to 20 years and the second was in patients over 60. We did not find significant temporal trends in the incidence of bone (EAPC=-1.14; >0.05) and soft tissue cancers (EAPC=-2.73; >0.05) during the study period.

CONCLUSION

Epidemiological features of bone and soft tissue cancers including gender, age and place of residence should be considered by health policy makers in designing cancer control programs.

摘要

背景

本研究旨在评估 2004 年至 2016 年伊朗北部戈勒斯坦省骨和软组织癌症的流行病学特征。

方法

这是一项描述性的横断面研究。所有 2004 年至 2016 年期间患有原发性骨和软组织癌症的患者均纳入研究。数据来自戈勒斯坦人群癌症登记处(GPCR)。我们计算了年龄标准化发病率(ASR),并报告了每 100000 人年的发病率。还计算了估计的年百分变化(EAPC),以评估这些癌症发病率的时间趋势。

结果

骨癌和软组织癌的 ASR 分别为 1.33 和 1.43/100000 人年。本研究还表明,男性骨癌的 ASR(1.51)高于女性(1.15)。城市人口的软组织癌 ASR(1.58)高于农村(1.27),女性(1.37)低于男性(1.49)。骨癌的发病率有两个高峰。第一个高峰在 10 至 20 岁年龄组,第二个高峰在 60 岁以上患者中。在研究期间,我们未发现骨癌(EAPC=-1.14;>0.05)和软组织癌(EAPC=-2.73;>0.05)发病率的显著时间趋势。

结论

卫生政策制定者在制定癌症控制计划时应考虑骨和软组织癌症的流行病学特征,包括性别、年龄和居住地。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/6a78be594a8c/aim-26-62-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/05210d6820f6/aim-26-62-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/492b66a03937/aim-26-62-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/e37be7fb7f0c/aim-26-62-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/d90fbecb7350/aim-26-62-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/6a78be594a8c/aim-26-62-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/05210d6820f6/aim-26-62-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/492b66a03937/aim-26-62-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/e37be7fb7f0c/aim-26-62-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/d90fbecb7350/aim-26-62-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/10685894/6a78be594a8c/aim-26-62-g005.jpg

相似文献

1
Incidence and Temporal Variations of Bone and Soft Tissue Cancers in the Golestan Province, Northern Iran, 2004-2016.2004-2016 年伊朗北部戈勒斯坦省骨和软组织癌的发病率及时间变化。
Arch Iran Med. 2023 Feb 1;26(2):62-68. doi: 10.34172/aim.2023.11.
2
Epidemiology of Head and Neck Cancers in Northern Iran: A 10-Year Trend Study From Golestan Province.伊朗北部头颈癌的流行病学:来自戈勒斯坦省的一项10年趋势研究。
Arch Iran Med. 2018 Sep 1;21(9):406-411.
3
Trends in the Incidence of Stomach Cancer in Golestan Province, a High-risk Area in Northern Iran, 2004-2016.2004-2016 年伊朗北部高危地区戈勒斯坦省胃癌发病率趋势。
Arch Iran Med. 2020 Jun 1;23(6):362-368. doi: 10.34172/aim.2020.28.
4
Temporal and Geographical Trends of Incidence of Thyroid Cancer in Golestan, Iran, 2004-2013.2004-2013 年伊朗戈勒斯坦甲状腺癌发病率的时间和地理趋势。
Arch Iran Med. 2021 Jan 1;24(1):1-6. doi: 10.34172/aim.2021.01.
5
Descriptive Epidemiology of Lymphoma in Northern Iran: Results from the Golestan Registry 2004-2013.伊朗北部淋巴瘤的描述性流行病学:2004 - 2013年戈勒斯坦登记处的结果
Arch Iran Med. 2020 Mar 1;23(3):150-154.
6
Temporal and geographical variations in colorectal cancer incidence in Northern Iran 2004-2013.2004-2013 年伊朗北部结直肠癌发病率的时间和地域变化。
Cancer Epidemiol. 2019 Apr;59:143-147. doi: 10.1016/j.canep.2019.02.003. Epub 2019 Feb 13.
7
Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry.伊朗戈勒斯坦原发性胆管癌:戈勒斯坦人群癌症登记处 13 年经验。
Arch Iran Med. 2023 Sep 1;26(9):504-509. doi: 10.34172/aim.2023.76.
8
Building cancer registries in a lower resource setting: The 10-year experience of Golestan, Northern Iran.在资源匮乏地区建立癌症登记处:伊朗北部戈勒斯坦省的十年经验。
Cancer Epidemiol. 2018 Feb;52:128-133. doi: 10.1016/j.canep.2017.12.014. Epub 2018 Jan 4.
9
Incidence, Time Trends and Geographical Distribution of Leukemia and Multiple Myeloma in Golestan Province, Northern Iran, 2004-2017.伊朗北部戈勒斯坦省 2004-2017 年白血病和多发性骨髓瘤的发病率、时间趋势和地理分布。
Arch Iran Med. 2022 Jun 1;25(6):360-365. doi: 10.34172/aim.2022.59.
10
Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008.戈勒斯坦省癌症发病率:伊朗 2004 年至 2008 年基于人群的癌症登记处的报告。
Arch Iran Med. 2012 Apr;15(4):196-200.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Incidence and time trends of sarcoma (2000-2013): results from the French network of cancer registries (FRANCIM).肉瘤的发病率和时间趋势(2000-2013):来自法国癌症登记处网络(FRANCIM)的结果。
BMC Cancer. 2020 Mar 6;20(1):190. doi: 10.1186/s12885-020-6683-0.
3
Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China.
中国软组织肉瘤的发病率、组织学亚型分布及原发部位
Cancer Biol Med. 2019 Aug;16(3):565-574. doi: 10.20892/j.issn.2095-3941.2019.0041.
4
Incidence and Mortality of Sarcomas in Shanghai, China, During 2002-2014.2002 - 2014年中国上海肉瘤的发病率和死亡率
Front Oncol. 2019 Jul 17;9:662. doi: 10.3389/fonc.2019.00662. eCollection 2019.
5
Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea.韩国晚期软组织肉瘤患者的特征和治疗模式。
Cancer Res Treat. 2019 Oct;51(4):1380-1391. doi: 10.4143/crt.2018.476. Epub 2019 Feb 18.
6
Bone Cancer: Diagnosis and Treatment Principles.骨肿瘤:诊断与治疗原则。
Am Fam Physician. 2018 Aug 15;98(4):205-213.
7
Incidence and Mortality of Various Cancers in Iran and Compare to Other Countries: A Review Article.伊朗各类癌症的发病率和死亡率及其与其他国家的比较:一篇综述文章
Iran J Public Health. 2018 Mar;47(3):309-316.
8
Building cancer registries in a lower resource setting: The 10-year experience of Golestan, Northern Iran.在资源匮乏地区建立癌症登记处:伊朗北部戈勒斯坦省的十年经验。
Cancer Epidemiol. 2018 Feb;52:128-133. doi: 10.1016/j.canep.2017.12.014. Epub 2018 Jan 4.
9
Incidences of Primary Soft Tissue Sarcoma Diagnosed on Extremities and Trunk Wall: A Population-Based Study in Taiwan.台湾地区基于人群的肢体及躯干壁原发性软组织肉瘤发病率研究
Medicine (Baltimore). 2015 Oct;94(41):e1696. doi: 10.1097/MD.0000000000001696.
10
Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care.2015年法国软组织肉瘤:临床护理的流行病学、分类及组织情况
J Visc Surg. 2015 Sep;152(4):223-30. doi: 10.1016/j.jviscsurg.2015.05.001. Epub 2015 Jun 15.